JESSICA KEARNEY: Open Payments
NPI 1538652987 · WHITESBURG, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 39 payments from 14 companies in 2025. Trend: 2023 $1,115 · 2024 $1,276 · 2025 $920
Food & beverage: $920
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $193 |
| PFIZER INC. | 8 | $153 |
| Phathom Pharmaceuticals, Inc. | 2 | $140 |
| Novo Nordisk Inc | 5 | $122 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| Grifols USA, LLC | 1 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Amgen Inc. | 2 | $30 |
Products named: ELIQUIS, VOQUEZNA, OFEV, Ozempic, JARDIANCE, GEMTESA, Prolastin-C Liquid, Kerendia.
Industry payments across GA — which companies pay providers there.
